
==== Front
Ann Hematol
Ann Hematol
Annals of Hematology
0939-5555
1432-0584
Springer Berlin Heidelberg Berlin/Heidelberg

38519606
5709
10.1007/s00277-024-05709-9
Correction
Correction to: Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patientreported outcomes from the CARDINAL study
Röth Alexander alexander.roeth@uk-essen.de

1
Barcellini Wilma 2
Anderson Tvedt Tor Henrik 3
Miyakawa Yoshitaka 4
Kuter David J. 5
Su Jun 6
Jiang Xiaoyu 6
Hobbs William 6
Morales Jaime 6
Shafer Frank 6
Weitz Ilene C. 7
1 https://ror.org/04mz5ra38 grid.5718.b 0000 0001 2187 5445 Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
2 https://ror.org/016zn0y21 grid.414818.0 0000 0004 1757 8749 Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
3 https://ror.org/03np4e098 grid.412008.f 0000 0000 9753 1393 Section for Hematology, Department of Medicine, Haukeland University Hospital, Bergen, Norway
4 https://ror.org/02tyjnv32 grid.430047.4 0000 0004 0640 5017 Department of General Internal Medicine, Saitama Medical University Hospital, Saitama, Japan
5 grid.38142.3c 000000041936754X Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston, MA USA
6 Sanof, Cambridge, MA USA
7 https://ror.org/03taz7m60 grid.42505.36 0000 0001 2156 6853 Jane Anne Nohl Division of Hematology, Department of Medicine, University of Southern California – Keck School of Medicine, Los Angeles, CA USA
23 3 2024
23 3 2024
2024
103 5 18031803
© Springer-Verlag GmbH Germany, part of Springer Nature 2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
issue-copyright-statement© Springer-Verlag GmbH Germany, part of Springer Nature 2024
==== Body
pmc Correction to: Annals of Hematology

10.1007/s00277-022-04948-y

After publication of this paper, an error﻿ was made in the fourth paragraph of column 2 on page 2170, regarding the description of the possible score range of the SF-12 Mental Component Summary (MCS) and Physical Component Summary (PCS). In both places, the score range for the MCS and PCS was stated to be 0–100. These two measures are actually reported on a T-score metric, which has a mean of 50 and standard deviation (SD) of 10.

The text should be changed from: “(PCS and MCS, respectively; summary scores range 0–100)” to “(PCS and MCS scores are on a T-metric, with mean = 50 and SD = 10, referenced to the US general population)”.

The original article has been corrected.

The online version of the original article can be found at 10.1007/s00277-022-04948-y.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
